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Growth Differentiation Factor 5 Regulates
Cardiac Repair After Myocardial Infarction
Syed H. E. Zaidi, PHD,*†§ Qingling Huang, PHD,§ Abdul Momen, MD,§ Ali Riazi, PHD,
Mansoor Husain, MD*†‡
Toronto, Ontario, Canada
Objectives The aim of this study was to examine the function of the bone morphogenic protein growth differentiation factor
5 (Gdf5) in a mouse model of myocardial infarction (MI).
Background The Gdf5 has been implicated in skeletal development, but a potential role in the heart had not been studied.
Methods The Gdf5-knockout (KO) and wild-type (WT) mice were subjected to permanent left anterior descending coronary
artery (LAD) ligation. Cardiac pathology, function, gene expression levels, and signaling pathways downstream of
Gdf5 were examined. Effects of recombinant Gdf5 (rGdf5) were tested in primary cardiac cell cultures.
Results The WT mice showed increased cardiac Gdf5 levels after MI, with increased expression in peri-infarct cardiomyo-
cytes and myofibroblasts. At 1 and 7 days after MI, no differences were observed in ischemic or infarct areas
between WT and Gdf5-KO mice. However, by 28 days after MI, Gdf5-KO mice exhibited increased infarct scar
expansion and thinning with decreased arteriolar density compared with WT. The Gdf5-KO hearts also displayed
increased left ventricular dilation, with decreased contractility after MI. At 4 days after MI, Gdf5-KO mice exhib-
ited increased cardiomyocyte apoptosis and decreased expression of anti-apoptotic genes Bcl2 and Bcl-xL com-
pared with WT. Unexpectedly, Gdf5-KO hearts displayed increased Smad 1/5/8 phosphorylation but decreased
p38-mitogen-activated protein kinase (MAPK) phosphorylation versus WT. The latter was associated with in-
creased collagen gene (Col1a1, Col3a1) expression and fibrosis. In cultures, rGdf5 induced p38-MAPK phosphor-
ylation in cardiac fibroblasts and Smad-dependent increases in Bcl2 and Bcl-xL in cardiomyocytes.
Conclusions Increased expression of Gdf5 after MI limits infarct scar expansion in vivo. These effects might be mediated by
Gdf5-induced p38-MAPK signaling in fibroblasts and Gdf5-driven Smad-dependent pro-survival signaling in
cardiomyocytes. (J Am Coll Cardiol 2010;55:135–43) © 2010 by the American College of Cardiology
Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.08.041i
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orowth differentiation factor 5 (Gdf5), also known as bone
orphogenetic protein (BMP) 14, is a secreted morphogen of
he transforming growth factor-beta super-family, conferring
ignaling by activation of Smad 1/5/8 or mitogen-activated
rotein kinase (p38-MAPK) (1,2). The Gdf5 is one of the few
orphogenetic proteins that interact with both type 2 BMP
nd activin receptors with equivalent affinities (3). This ability
f Gdf5 and its persistent expression in postnatal tissues posit
potentially important role.
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nstitutes of Health Research (MOP117801) and HSFO (CI: 5503) to Dr. Husain.a
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ccepted August 3, 2009.During development, Gdf5 is expressed in several tissues
ncluding the heart (4–6). Studies in vitro suggest that Gdf5 has
ffects on angiogenesis (7,8), apoptosis (9), cell survival (6),
ifferentiation (10), and migration (7). Although Gdf5 expression
ontinues into adulthood in some tissues (4), its role in the heart
ad not been studied. Mutations in Gdf5 produce skeletal disor-
ers in humans and in mice (4). Gdf5-deficient mice exhibit
educed revascularization and delayed healing after tendon injury
11). Given these findings, we hypothesized that Gdf5 might
nfluence remodeling and repair processes in the heart.
See page 144
Here we show that Gdf5 protein and its receptors are
xpressed in the adult mouse heart and that Gdf5 levels are
levated after myocardial infarction (MI). To study the role of
df5 in cardiac repair, we compared the structure and function
f Gdf5-knockout (KO) and wild-type (WT) hearts after left
nterior descending coronary artery (LAD) ligation. To exam-
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normal cardiac repair in Gdf5-KO
mice, we studied Smad 1/5/8 and
p38-MAPK signaling, collagen
gene expression, fibrosis, apoptosis,
and vascularization. In addition,
we examined the effects of Gdf5
on survival of neonatal cardiomy-
ocytes. This is the first report
of the effects of Gdf5 deficiency
in particular and a BMP family
member in general on cardiac
repair.
Methods
Animals. The C57Bl6 mice and
mice heterozygous for the Gdf5
(bp3J allele) were purchased from
Jackson Laboratory (Bar Harbor,
Maine). Heterozygous mice were
crossed to obtain homozygous KO
and WT littermates.
Surgery and hemodynamic pro-
cedures. Mice (8 to 12 weeks of
age) were subjected to LAD liga-
tion or sham surgery according to
protocols approved by our institu-
tional Animal Care Committee.
Experimental procedures for this
model are detailed elsewhere (12).
For in vivo hemodynamic mea-
surements, mice were anesthetized
with 1% isoflurane, and the right
carotid artery was cannulated with
a micromanometer catheter (Mil-
lar Instruments, Houston, Texas).
eart rate, aortic blood pressures, left ventricular (LV) systolic
ressure, and peak positive and negative first derivatives of the
V pressure (dP/dt) were recorded.
everse-transcriptase polymerase chain reaction. Ribo-
ucleic acid (RNA) was isolated and reverse-transcribed with
he SuperScript III kit (Invitrogen, Burlington, Ontario, Can-
da). Quantitative real-time polymerase chain reaction (PCR)
as performed with SYBR green as per the manufacturer
Applied Biosystems, Streetsville, Ontario, Canada). Real-
ime data were normalized to glyceraldehyde-3-phosphate
ehydrogenase complementary deoxyribonucleic acid. Primer
equences are listed in Supplementary Table A.
istology, immunohistochemistry, and Western blot.
earts were fixed in 10% formalin, paraffin-embedded,
ectioned (5 m), and stained with hematoxylin and eosin
r trichrome. Images were captured and analyzed by Image
software (National Institute of Health). Infarct area,
ransmurality, and expansion index were calculated as de-
cribed (13). Antibody against Gdf5 (R&D Systems, Min-
Abbreviations
and Acronyms
AW  anterior wall
ERK  extracellular signal
regulated kinase
Gdf5  growth
differentiation factor 5
ID1  inhibitor of
differentiation 1
LAD  left anterior
descending coronary artery
LV  left ventricle/
ventricular
MAPK  mitogen-activated
protein kinase
MI  myocardial infarction
MMP  matrix
metalloproteinase
mRNA  messenger
ribonucleic acid
KO  knockout
rGdf5  recombinant
growth differentiation
factor 5
RNA  ribonucleic acid
RNAi  ribonucleic acid
interference
RT-PCR  reverse-
transcriptase polymerase
chain reaction
SM  smooth muscle
TUNEL  terminal
deoxynucleotidyl
transferase (TdT)-mediated
dUTP nick end labeling
WT  wild-typeeapolis, Minnesota; and Santa Cruz Biotechnology, Santa Pruz, California), smooth muscle (SM)-alpha-actin (Dako,
ississauga, Ontario, Canada), activated caspase 3, phos-
horylated Smad 1/5/8, phosphorylated and total p38-
APK, extracellular signal regulated kinase (ERK)1/2 and
-jun N-terminal kinase, Bcl2 and Bcl-xL (Cell Signaling
echnology, Danvers, Massachusetts), total Smad 1/5/8
nd inhibitor of differentiation 1 (ID1) (Santa Cruz Bio-
echnology, Santa Cruz, California), HRP-conjugated sec-
ndary antibodies (Bio-Rad, Mississauga, Ontario, Can-
da), and the Vectastain kit (Vector Laboratories,
urlington, Ontario, Canada) were employed for immuno-
istochemistry and/or Western blot. Myocardial fibrosis
as assessed by trichrome as described (12).
ell culture. Neonatal mouse cardiac fibroblasts and car-
iomyocytes were prepared as described (14,15) (Supple-
entary Fig. 1). Cells were cultured in Dulbecco’s modified
agle’s media/F12 media containing 10% serum. Passage 2
broblasts were kept in 0.1% serum containing medium for
8 h and stimulated with recombinant Gdf5 (rGdf5, R&D
ystems) at a concentration of 250 ng/ml. Cardiomyocytes
ere treated with buffer or rGdf5 at a concentration 250
g/ml. Terminal deoxynucleotidyl transferase (TdT)-
ediated dUTP nick end labeling (TUNEL) was per-
ormed with the CardioTACS kit (R&D Systems).
ibonucleic acid interference (RNAi). Stealth RNAi
gainst mouse Gdf5, Smad 4, p38-MAPK (Mapk14),
egative control, BlockiT alexa Fluor, and lipofectamine
000 were purchased from Invitrogen. The RNAi were
ransfected at a final concentration of 20 nmol/l as described
y the manufacturer, and gene expression was assessed by
uantitative real time reverse-transcriptase polymerase chain
eaction (RT-PCR).
tatistical methods. Data for Gdf5 expression, ventricular to
ody weight ratios, and vascularity were analyzed by 2-way
nalysis of variance followed by Bonferroni test for multiple
omparisons among groups. When only 2 groups were com-
ared, the Student t test was applied. Collagen expression data
ere analyzed by single factor analysis of variance followed by
tudent t test. All values shown are mean  SEM.
esults
dult mouse heart expresses Gdf5 and its receptors. To
onclusively establish that Gdf5 is expressed in the heart,
T-PCR was performed on messenger ribonucleic acid
mRNA) from whole adult mouse hearts (n  3). The
mplified product was sequenced to confirm Gdf5 expression
Fig. 1A). Similarly, RT-PCR was used to confirm the
xpression of BMP and activin receptors through which Gdf5
ransduces its signals. Both type 1 (Bmpr1b) and type 2
Bmpr2, Acvr2a, Acvr2b) receptors were expressed.
ardiac Gdf5 expression is increased after MI. Anterior
alls (AWs) (infarct) and posterior walls (PW) (noninfarct) of
he LV were dissected for RNA extraction. The RT-PCR
evealed serial increases in Gdf5 mRNA levels in the infarct-
ontaining AW. To quantify this, real-time quantitative RT-
CR was also performed. Compared with sham and nonsur-
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January 12, 2010:135–43 Gdf5 Regulates Cardiac Repairery control subjects, Gdf5 mRNA levels were elevated at 7
nd 14 days after MI (Fig. 1B). The Gdf5 mRNA levels at 7
nd 14 days after MI were 8.5- and 11.6-fold higher, respec-
ively, in the AW of infarcted mice as compared with the AW
f 7-day sham-operated control subjects (p  0.025). In-
reased cardiac Gdf5 protein expression after MI was con-
rmed by Western blot (Fig. 1C), which revealed that Gdf5
rotein levels remained elevated up to 40 days after MI
reaching maximum levels at 21 days). Immunohistochemistry
t 14 days showed elevated Gdf5 expression in cardiomyocytes
Fig. 1D) and myofibroblasts (Fig. 1E) in the peri-infarct areas
f the heart after MI.
df5-deficient mice exhibit adverse infarct remodeling.
etrazolium staining of heart sections at 1 day after MI
howed no difference in ischemic area between Gdf5-KO
nd WT mice. Infarct area at 7 days after MI also did not
iffer between Gdf5-KO and WT mice. However, by 28
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Figure 1 Gdf5 Levels Are Regulated After MI
(A) Reverse-transcriptase polymerase chain reaction–defined expression of growth
receptors in the adult mouse heart. (B) Real-time quantification of Gdf5 messenge
(noninfarct). All data were normalized to glyceraldehyde-3-phosphate dehydrogenas
 SEM (n  3 mice/bar). Data were compared by 2-way analysis of variance (ANO
cardiac Gdf5 protein levels are evident 7, 21, and 40 days after myocardial infarct
shows elevated Gdf5 protein expression in peri-infarct cardiomyocytes at 14 days
nifications of the Gdf5-stained section. (E) The Gdf5 expression (brown staining,
fibroblasts (blue staining, left panel). The right panel is counterstained with hema
muscle cell-alpha actin. *p  0.025; †p  0.003. LAD  left anterior descendingays after MI, morphometry revealed a 42% greater infarct Mrea in Gdf5-KO mice as compared with WT control
ubjects (Table 1). At 28 days after MI, ventricular weight
o body weight ratio was elevated by 9% in Gdf5-KO as
ompared with WT (Fig. 2). At this time point, hearts from
df5-KO mice exhibited a 30% increase in thinning of the
nfarcted LV and transmural infarct expansion (Table 1).
he full thickness extent of the infarct (i.e., its transmural-
ty) at 28 days after MI, as quantified by 2 different formulae
13), was significantly greater in Gdf5-KO as compared
ith WT mice (Table 1). Finally, quantification of dilation
nd thinning of the infarct wall (13) revealed 156% greater
nfarct expansion (infarct topography and area without
dditional necrosis) in Gdf5-KO mice (Table 1). These data
ndicate that Gdf5 plays an important role in preventing
nfarct wall thinning, cardiac dilation, and infarct expansion.
df5-deficient mice exhibit impaired cardiac function
fter MI. Terminal hemodynamic studies at 28 days after
b
d
entiation factor 5 (Gdf5) and bone morphogenetic protein (BMP) and activin
ucleic acid (mRNA) expression in the anterior walls (infarct) and posterior walls
dh) mRNA Bar “c” represents noninfarcted control. All data are given as mean
 0.001) followed by Bonferroni test for multiple comparisons. (C) Elevated
I). Recombinant Gdf5 (rGdf5) is a positive control. (D) Immunohistochemistry
I (a, c, and d). IgG control was used in panel b. Panels c and d are higher mag-
anel) was also observed in smooth muscle cell-alpha actin-positive cardiac myo-
(blue) to visualize nuclei. Arrows denote cells which are stained for smooth
ary artery; LV  left ventricle.D
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Gdf5 Regulates Cardiac Repair January 12, 2010:135–43unction in LAD-ligated Gdf5-KO and WT mice as
ompared with their respective sham-operated control sub-
ects (data not shown). However, within LAD-ligated
roups, Gdf5-KO mice displayed significantly greater re-
uctions in indexes of cardiac function than their WT
ontrol subjects (Table 2). In sham control subjects, param-
ters of cardiac function did not differ between Gdf5-KO and
T mice. However, mean arterial pressure was somewhat
ower in Gdf5-KO (77  2.5, n  10) versus WT (92  3.9,
 12) mice (p  0.05). Although cardiac function of
df5-KO and WT did not differ at 8 days after MI, it was
ignificantly reduced in Gdf5-KO mice at 14 days after MI
Supplementary Table B).
ifferential activation of p38-MAPK and Smad 1/5/8 in
df5-KO and WT hearts. As known downstream medi-
tors of BMP or Gdf5 signaling in other tissues (1,2,16), the
ctivation (i.e., phosphorylation) of Smad 1/5/8 and p38-
APK was first examined by Western blot of heart lysates
rom WT mice. Although total Smad 1/5/8 and p38-MAPK
rotein levels did not change, Smad 1/5/8 phosphorylation
orphometry DataTable 1 Morphometry Data
Parameters WT KO p Value
Infarct area, 7 days after MI 34.95 5.68 31.97 4.74 0.403
Infarct area, 28 days after MI 31.73 2.98 45.10 4.25 0.013
Infarct thickness, 28 days after MI 0.64 0.05 0.45 0.04 0.007
Degree of transmurality (%),
28 days after MI 61.89 6.59 83.13 3.03 0.009
Area subtended by infarct (%),
28 days after MI 61.06 3.87 87.28 2.72 0.0001
Expansion index, 28 days after MI 0.70 0.10 1.79 0.35 0.003
nfarct area ([infarct area/total left ventricle (LV) area] 100) was calculated at 7 days for growth
ifferentiation factor 5 (Gdf5)-knockout (KO) and wild-type (WT) (n 7 each) mice and 28 days for
df5-KO (n  16) and WT mice (n  19). Infarct thickness was calculated by averaging thickness
f the infarct over 5 equally spaced locations and dividing by thickness of the noninfarcted LV
easured at mid-septum. Transmurality was defined as infarct length touching the epicardium
ivided by total infarct length. Area subtended by the infarct was determined by the formula: infarct
rea/entire LV area subtended by outer infarct margin. Expansion index was calculated as
escribed in the Results section. All data are mean  SEM. Analyses were by Student t test.
MI  myocardial infarction.
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Figure 2 Gdf5-Deficiency Adversely Affects Cardiac Remodeling
(A) Ventricle to body weight ratios at 28 days after MI or sham. (B) Representativ
Data are mean  SE. Analysis was by 2-way ANOVA followed by Bonferroni test. Kncreased slightly at 14 days after MI, and p38-MAPK
hosphorylation was decreased at both 7 and 14 days after MI
Fig. 3A). We next compared expression and phosphorylation
f these signaling proteins in the hearts of Gdf5-KO and -WT
ice at 7 days after MI. Although total Smad 1/5/8 and
38-MAPK levels did not differ between Gdf5-KO and WT
earts, phosphorylation of Smad 1/5/8 was increased approx-
mately 3-fold in Gdf5-KO hearts, whereas phosphorylation of
38-MAPK was reduced approximately 80% (Fig. 3B). In-
reased phosphorylated Smad 1/5/8 in Gdf5-KO hearts was
redominantly present within the infarct area (Supplementary
ig. 2). At this time point, activated levels of ERK1/2 and
-jun N-terminal kinase did not differ between Gdf5-KO and
T mice (data not shown). These experiments revealed that
df5 deficiency results in a significant and seemingly selective
eduction in p38-MAPK signaling after MI.
df5 deficiency increased collagen gene expression and
brosis after MI. Signaling via p38-MAPK is known to
uppress collagen type I, alpha-1 (Col1a1) and collagen type
II, and alpha-1 (Col3a1) gene transcription in cardiac cells
17) and to reduce cardiac fibrosis after MI (18). Because
df5-KO mice manifest reduced p38-MAPK phosphoryla-
ion after MI, we next examined collagen gene expression and
brosis in WT and Gdf5-KO mice. In WT mice, Col1a1
TW
2mm
r MI
rome-stained sections of 28 days after MI hearts.
nockout; WT  wild-type; other abbreviations as in Figure 1.
emodynamic DataTable 2 Hemodynamic Data
Parameters (28 Days After MI) WT (n > 16) KO (n  18) p Value
HR (beats/min) 565 15 545 12 0.298
SBP (mm Hg) 96 3.5 82 2.7 0.004
DBP (mm Hg) 78 3.4 68 2.4 0.026
MAP (mm Hg) 84 3.4 73 2.5 0.013
LVSP (mm Hg) 101 4.1 85 3.0 0.004
dP/dt (mm Hg/s) 4,627 179 3,812 135 0.001
dP/dt (mm Hg/s) 4,531 173 3,802 151 0.003
ata were analyzed by Student t test. All data are mean  SEM.
DBP  aortic diastolic blood pressure; dP/dt  peak first derivatives of change in left ventricular
ressure/time; HR  heart rate; LVSP  peak left ventricular systolic pressure; MAP  mean aortic
lood pressure; SBP  aortic systolic blood pressure; other abbreviations as in Table 1.Afte
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January 12, 2010:135–43 Gdf5 Regulates Cardiac RepairFig. 4A) and Col3a1 (Fig. 4B) mRNA levels in the infarct
one were elevated 19- and 16-fold, respectively, above sham-
perated control subjects at 7 days after MI and 49- and
4-fold, respectively, at 14 days after MI. In Gdf5-KO mice,
ol1a1 and Col3a1 mRNA levels were an additional 2.6- and
.2-fold higher than in WT hearts at the 7-day time point. By
4 and 28 days after MI, this difference was no longer
pparent, because Col1a1 and Col3a1 levels were similarly
levated in Gdf5-KO and WT mice versus sham. Of note,
here were no differences in matrix metalloproteinase
MMP)-9 and MMP-2 levels between Gdf5-KO and WT
earts at 7 and 28 days after MI (Supplementary Fig. 3).
ibrosis was 46% greater in Gdf5-KO mice hearts, compared
ith WT mice, after MI (Fig. 4C). These studies showed that
df5 deficiency results in increased Col1a1 and Col3a1
RNA expression and fibrosis after MI.
df5 deficiency reduced the numbers of myocardial vessels
fter MI. Coronary artery occlusion is known to remodel the
yocardial vasculature (19,20), and expression of phosphory-
ated p38-MAPK after MI has been correlated with vascular
ensity and inversely correlated with infarct area (18). Accord-
Phospho-p38 
MAP Kinase
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p38 MAP 
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Smad 1/5/8
WT                 
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p38 MAP 
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0
MI
7 14  days
Control
Control
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Figure 3 Gdf5-Deficiency Alters Smad and p38 Signaling After
Phosphorylated and total p38 mitogen-activated protein kinase (MAPK) and Smad
MI Gdf5-KO and WT mice. Right panels show densitometric ratios of phosphorylat
p38-MAPK and Smad 1/5/8 levels are similar in nonsurgical Gdf5-KO and WT conngly, we examined arterial density in Gdf5-KO mice with Tmooth muscle (SM)-alpha-actin to identify muscular pre-
apillary vessels. In the infarct region (infarct and border area),
he number of SM-alpha-actin–stained vessels was reduced by
7% in Gdf5-KO hearts as compared with WT (Fig. 5),
hereas the number of these vessels in noninfarcted regions
id not differ. Similarly, in sham-operated control subjects, the
umber of SM-alpha-actin–stained cardiac vessels did not
iffer between Gdf5-KO and WT mice. At 14 days after MI,
D1 expression did not differ between the Gdf5-KO and WT
ice (Supplementary Fig. 4). These observations showed that
df5 deficiency results in reduced numbers of muscular myo-
ardial arteries, an effect independent of ID1 but consistent
ith reduced p38-MAPK signaling.
df5 improved cardiomyocyte survival and increased
xpression of anti-apoptotic genes via Smad signaling. Be-
ause less viable myocardium was ultimately observed in
df5-KO mice at 28 days after MI (Fig. 2, Table 1), we
lso explored whether Gdf5 has effects on cardiomyocyte
urvival. In a cell culture model of serum-deprivation–
nduced apoptosis (21), the number of TUNEL-positive
uclei was reduced by 79% in rGdf5-treated cells (Fig. 6A).
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Gdf5 Regulates Cardiac Repair January 12, 2010:135–43evels of Bcl-xL, Bcl2, and Bax. The pro-survival effect of
Gdf5 was accompanied by 53% and 138% increases in
xpression of the anti-apoptotic genes Bcl2 and Bcl-xL,
espectively (Fig. 6B), with no change in the expression of
he pro-apoptotic gene Bax. Of note, these effects of rGdf5
ere also observed in the absence of an apoptotic insult (i.e.,
n serum-stimulated cardiomyocytes). These data suggest
hat Gdf5 might confer cardiomyocyte survival by elevating
Figure 4 Gdf5-Deficiency Increases Expression of Col1a1 and
Col3a1 mRNA Levels and Cardiac Fibrosis After MI
Real-time quantification of (A) Col1a1 and (B) Col3a1 mRNA levels in the
infarct zones of hearts after MI. All data were normalized to Gapdh mRNA and
sham control subjects and are given as mean  SEM; n  3 mice for each bar
in sham, and n  6 to 7 for each bar in post-MI. Data were compared by 1-way
ANOVA followed by t test for multiple comparisons. All post-MI expression lev-
els are higher than sham control subjects. *p  0.001. (C) Area of fibrosis
was calculated on trichrome-stained sections of hearts at 28 days after MI.
Data are mean  SEM. Abbreviations as in Figures 1 and 2.xpression of Bcl2 and Bcl-xL.To explore signaling mechanisms mediating the anti-
poptotic effects of rGdf5 in neonatal cardiomyocytes, we
mployed RNAi against Smad4, which is essential for Smad
/5/8 signaling, and p38 MAPK. The RNAi to Smad4
ecreased endogenous Smad4 (Fig. 7A) and blocked rGdf5-
nduced expression of Bcl-xL (Fig. 7B) and suppression of
poptosis (Fig. 7C). These effects were not observed with
NAi against p38-MAPK (Mapk14) (data not shown).
onsistent with our in vitro findings, Gdf5-KO mice hearts
howed increased apoptosis and decreased Bcl2 and Bcl-xL
xpression in the peri-infarct areas at 4 days after MI,
ompared with WT mice (Fig. 8).
df5 induces p38-MAPK phosphorylation in cardiac fibro-
lasts. To examine whether rGdf5 activates p38-MAPK,
ardiac fibroblasts and cardiomyocytes were treated with
Gdf5. Phosphorylation of p38-MAPK was rapidly induced
n cardiac fibroblasts treated with rGdf5 (Fig. 6C), with
P < 0.001
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Figure 5 Gdf5-Deficiency Reduces Abundance
of Muscularized Myocardial Arteries After MI
Sections were immunostained for smooth muscle-alpha-actin, and only stained
vessels of 15 to 100 m diameter were counted under a light microscope
(40 objective) and averaged for each section. Vessels were counted in the
anterior wall, including in normal tissue for sham, and in the infarct and border
zones for LAD-ligated hearts. Data were analyzed by 2-way ANOVA (p  0.05)
followed by Bonferroni test. (A) Representative sections from the peri-infarct
(left panels) and infarct (right panels) areas of the post-MI Gdf5-KO and WT
hearts are shown. (B) Data are plotted as number of vessels/microscopic field
and bars represent mean  SEM. Abbreviations as in Figures 1 and 2.
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January 12, 2010:135–43 Gdf5 Regulates Cardiac Repairotal p38-MAPK protein levels remaining unchanged. Of
nterest, activation of p38-MAPK was not observed in
Gdf5-treated cardiomyocytes.
iscussion
lthough some BMPs had been studied in cardiac devel-
pment, their role in repair of the adult heart had not. We
ow show that Gdf5 (a.k.a., BMP14) is expressed in the
dult mouse heart and that its levels are elevated after 7 days
fter MI. We further show that the receptors through which
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Figure 6
Recombinant Gdf5 Improves Survival
of Neonatal Cardiomyocytes and Induces
p38-MAPK Phosphorylation in Cardiac Fibroblasts
(A) Cardiomyocytes apoptosis was determined by terminal deoxynucleotidyl
transferase (TdT)-mediated dUTP nick end labeling (TUNEL) labeling after 48 h
of serum-free culture supplemented with rGdf5 or buffer. Data shown are repre-
sentative of 3 independent experiments. (B) Quantitative real-time reverse-
transcriptase polymerase chain reaction show elevated expression of Bcl2
and Bcl-xL in Gdf5-treated cells. Gene expression data were normalized to
Gapdh and calculated as fold change versus buffer-treated control subjects
*p  0.05. (C) The rGdf5 induces phosphorylation of p38-MAPK in mouse car-
diac fibroblasts. Abbreviations as in Figures 1 and 3.df5 transduces its signals (3) are also expressed. MoreFigure 7 Smad4 RNAi Ablates Gdf5 Induction of Bcl-xL and
Suppression of Apoptosis in Neonatal Cardiomyocytes
(A) Smad4 ribonucleic acid interference (RNAi) decreases Smad4 mRNA levels
in neonatal cardiomyocytes. *p  0.05 versus other treatments; †p  0.001
versus control RNAi; n  3/treatment. (B) Smad4 RNAi ablates rGdf5 induc-
tion of Bcl-xL mRNA. *p  0.03 versus other treatments; †p  0.05 versus
buffer-treated control RNAi; n  3/treatment. (C) Neonatal cardiomyocyte were
transfected with Smad4 or control RNAi, and apoptosis was determined by
caspase 3 immunostaining after 48 h of serum free culture with rGdf5 or
buffer. *p  0.001 versus buffer-treated control RNAi; †p  0.007 versus
Gdf5-treated control RNAi; n  10 microscopic fields/treatment. Abbreviations
as in Figures 1.
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Gdf5 Regulates Cardiac Repair January 12, 2010:135–43mportantly, we are the first to show that the absence of this
MP results in impaired cardiac repair after MI, as manifest
y increased indexes of post-healing infarct scar expansion,
ncreased cardiomyocyte apoptosis, decreased vascular density,
nd accelerated functional deterioration in Gdf5-KO mice.
inally, our data suggest that the increased expression of Gdf5
fter MI serves to improve cardiac repair by Smad-dependent
eduction in cardiomyocyte apoptosis, enhanced p38-MAPK
hosphorylation in cardiac fibroblasts, suppression of collagen
xpression and fibrosis, and preservation of vascular density.
ogether, these findings enhance our understanding of the
echanisms and importance of the transforming growth
actor-beta super family in healing and repair after MI (22).
Hearts from Gdf5-KO mice exhibited increased ventri-
le/body weight ratio, infarct area, LV wall thinning,
ransmural infarct expansion, and cardiac dilation and thin-
ing. The Gdf5-KO mice also displayed worse hemody-
amic parameters after MI. Together these morphometric
P = 0.005
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Figure 8 Gdf5-KO Mice Exhibit Increased Apoptosis and
Reduced Expression of Bcl2 and Bcl-xL After MI
(A) Sections were immunostained for activated caspase-3. Apoptotic cells were
counted in the peri-infarct areas of post-MI hearts under a light microscope
(40 objective) and averaged for each section. (B) Post-MI heart sections were
immunostained for Bcl2 and Bcl-xL. In Gdf5-KO mice, expression of these genes
was lesser than the WT hearts after MI. Abbreviations as in Figures 1 and 2.nd functional studies indicate impaired cardiac repair and (unction in Gdf5-KO mice. To examine molecular causes
nderlying this phenotype, p38-MAPK and Smad 1/5/8
hosphorylation were studied in post-MI hearts. Compared
ith WT, Gdf5-KO mice exhibited decreased p38-MAPK
hosphorylation and increased Smad 1/5/8 phosphoryla-
ion. Although the unexpected increase in phosphorylated
mad 1/5/8 in the infarct area might be due to dysregulated
xpression of other BMPs or inhibitory Smads, the docu-
ented effects of Gdf5 deficiency on post-healing infarct
car expansion, apoptosis, vascular density, cardiac function,
nd fibrosis are entirely consistent with the decreased
38-MAPK phosphorylation observed in Gdf5-KO mice.
Indeed, several lines of evidence suggest that the pheno-
ype of Gdf5-deficient mice might be partly due to reduced
38-MAPK signaling. First, normalization of reduced p38-
APK phosphorylation in post-MI hearts has been shown
o reduce infarct area, increase vascular density, improve
ardiac function, and decrease cardiac fibrosis and apoptosis
18). Second, cardiomyocyte-specific p38-MAPK deletion
roduced massive cardiac fibrosis and elevated collagen
xpression after pressure overload (23). Third, p38-MAPK
hosphorylation is known to suppress Col1a1 and Col3a1
ranscription in cardiomyocytes (17).
Whether directly or indirectly dependent on p38-MAPK
ignaling, our findings of reduced numbers of muscular
rteries in the Gdf5-KO heart after LAD ligation are
onsistent with an important role for Gdf5 in tissue vascu-
arity. The Gdf5-KO mice have previously been shown to
ave a defect in revascularization after tendon injury (11),
nd rGdf5 is known to confer angiogenesis in chick cho-
ioallantoic membrane and rabbit cornea (8). The impor-
ance of this “vascular” effect on the post-MI phenotype of
df5-KO mice is likely to be high. Others have shown loss
f coronary arteries after MI, followed by a gradual increase
n capillary and arteriolar densities over 3 weeks (19). This
s believed to enhance blood flow, reduce infarct area, and
ontribute to cardio-protection in hypoxia-preconditioned
schemic hearts (19). Other studies supporting post-MI
ngiogenesis in mice include increased perfusion (20) and
mproved LV function after therapeutic angiogenesis (24).
s such, we believe that the decreased infarct-zone vascu-
arity of Gdf5-KO mice is a major contributor to the
ocumented increases in infarct thinning and expansion.
urther studies will be needed to explore what role, if any,
s played by Gdf5 on the abundance or recruitment of
irculating endothelial progenitors, cells known to partici-
ate in angiogenesis and repair after MI (25,26).
The Gdf5 is a pleiotropic BMP that is also known to
onfer anti-apoptotic and pro-apoptotic effects on different
ells (6,9). Here, we show that cardiomyocyte survival in
Gdf5-treated cells and in post-MI hearts is associated with
ncreased expression of Bcl-xL and Bcl2, which are potent
nhibitors of apoptosis. The Bcl2 gene transfer has also been
hown to improve post-MI repair by reducing cardiomyo-
yte apoptosis (27). In rat cardiomyocytes, BMP2 improved
ell survival by increasing Bcl-xL but not Bcl2 mRNA levels
21). Finally, rGdf5 induced rapid p38-MAPK phosphor-
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January 12, 2010:135–43 Gdf5 Regulates Cardiac Repairlation in cultured neonatal cardiac fibroblasts but not in
ardiomyocytes. Together, these data suggest complemen-
ary mechanisms through which the Gdf5 deficiency might
ave adversely affected repair after MI.
Our isolated finding of a mildly reduced systemic blood
ressure in noninfarcted (i.e., sham-operated) Gdf5-KO mice
s compared with WT mice might be related to the lower body
eight and shorter limbs of Gdf5-KO mice. Alternatively, this
ifference might suggest an additional role for Gdf5 in vascular
unction and blood pressure. Because no structural or func-
ional differences could be detected between the hearts of
ealthy Gdf5-KO and WT mice, additional studies will be
eeded to explore the basis of the blood pressure observation.
onclusions
e have shown that Gdf5 and its receptors are expressed in
dult mouse heart and that the Gdf5 levels are elevated after
I. The Gdf5-deficiency impaired cardiac repair after MI;
phenotype associated with reduced p38-MAPK phos-
horylation, elevated Col1a1 and Col1a3 mRNA levels,
ncreased fibrosis, enhanced apoptosis, and reduced vascu-
arization of the LV wall after MI. Having said this, Gdf5
s only one of several molecules involved in post-MI repair.
urthermore, uninjured Gdf5-KO mice survive without
ertinent abnormalities. Accordingly, overlapping expres-
ion of other BMPs or growth factors might be partially
ompensating for the loss of Gdf5 in the KO model.
espite this possibility, the perturbations caused by Gdf5
eficiency have promoted the initiation of irreversible events
hat led to decreased vascularity and greater loss of myocardium
n Gdf5-KO mice. Our results indicate that endogenous levels
f Gdf5 in particular and BMPs in general influence cardiac
epair after injury or ischemia. In addition, our study supports
he potential use of Gdf5-based therapies to improve repair
nd reduce progressive loss of cardiomyocytes after infarction.
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